Vaccine

Press Release Regarding Clinical Trials of a Vaccine Against SARS-Cov-2

IASc welcomes the exciting development of a candidate vaccine and wishes that the vaccine is quickly made available for public use. However, as a body of scientists – including many who are engaged in vaccine development – IASc strongly believes that the announced timeline is unfeasible.  This timeline has raised unrealistic hope and expectations in the minds of our citizens.